pubmed-article:11396995 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C0062534 | lld:lifeskim |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C1521733 | lld:lifeskim |
pubmed-article:11396995 | lifeskim:mentions | umls-concept:C0348080 | lld:lifeskim |
pubmed-article:11396995 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11396995 | pubmed:dateCreated | 2001-6-8 | lld:pubmed |
pubmed-article:11396995 | pubmed:abstractText | Hepatocyte growth factor (HGF) and its specific receptor, MET, are expressed in the developing and adult mammalian brain. Recent studies have shown a neurotrophic activity of HGF in the nervous system. The present study focused on HGF concentrations in the cerebrospinal fluid (CSF) and serum in normal persons and in different central nervous system (CNS) diseases considering blood-CSF barrier (BCB) function. Concentrations of HGF were analyzed using an enzyme-linked immunosorbent assay (ELISA). HGF was present in normal human CSF (346+/-126 pg/ml) representing approximately half of the HGF serum concentrations. The CSF HGF levels were not significantly changed in chronic CNS disease and in aseptic meningitis (419+/-71 pg/ml), but significantly increased in patients with bacterial meningitis (6101+/- 5200 pg/ml). The HGF levels in CSF were not influenced by increased serum concentrations in patients with normal or mildly affected BCB function. The results show that HGF is present in normal CSF and does not appear to cross the CSF barrier significantly unless it is severely disrupted. So far, strong increases of HGF concentration in CSF are only present in acute bacterial meningitis. | lld:pubmed |
pubmed-article:11396995 | pubmed:language | eng | lld:pubmed |
pubmed-article:11396995 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11396995 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11396995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11396995 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11396995 | pubmed:month | May | lld:pubmed |
pubmed-article:11396995 | pubmed:issn | 1043-4666 | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:SchubertDD | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:LindholmDD | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:BamborschkeSS | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:SchirmacherPP | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:NekicMM | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:RydinCC | lld:pubmed |
pubmed-article:11396995 | pubmed:author | pubmed-author:KernM AMA | lld:pubmed |
pubmed-article:11396995 | pubmed:copyrightInfo | Copyright 2001 Academic Press. | lld:pubmed |
pubmed-article:11396995 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11396995 | pubmed:day | 7 | lld:pubmed |
pubmed-article:11396995 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:11396995 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11396995 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11396995 | pubmed:pagination | 170-6 | lld:pubmed |
pubmed-article:11396995 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:meshHeading | pubmed-meshheading:11396995... | lld:pubmed |
pubmed-article:11396995 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11396995 | pubmed:articleTitle | Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions. | lld:pubmed |
pubmed-article:11396995 | pubmed:affiliation | Institute of Pathology, University of Cologne, Joseph-Stelzmann-Str. 9, D-50931 Cologne, Germany. | lld:pubmed |
pubmed-article:11396995 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11396995 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |